Therapies that target the molecular profile of non-small-cell lung cancer with the mutated cancer-causing protein KRas have been found to be the most effective treatment strategy for patients with the condition, researchers at University of Cincinnati (UC) Cancer Institute revealed.
These findings are being presented via poster at the American Association for Cancer Research- International Association for the Study of Lung Cancer Joint Conference on the Molecular Origins of Lung Cancer, Jan....
Therapies that target the molecular profile of non-small-cell lung cancer with the mutated cancer-causing protein KRas have been found to be the most effective treatment strategy for patients with the condition, researchers at University of Cincinnati (UC) Cancer Institute revealed.
These findings are being presented via poster at the American Association for Cancer Research- International Association for the Study of Lung Cancer Joint Conference on the Molecular Origins of Lung Cancer, Jan....